KVUE
Kenvue Inc.
Company Overview
| Mkt Cap | $30.34B | Price | $17.43 |
| Volume | 11.32M | Change | -0.57% |
| P/E Ratio | 20.6 | Open | $17.69 |
| Revenue | $15.1B | Prev Close | $17.53 |
| Net Income | $1.5B | 52W Range | $14.02 - $25.17 |
| Div Yield | 0.83% | Target | $19.09 |
| Overall | 61 | Value | 100 |
| Quality | 39 | Technical | 45 |
No chart data available
About Kenvue Inc.
Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. Its Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
Latest News
Analysts’ Opinions Are Mixed on These Consumer Goods Stocks: Costco (COST) and Kenvue, Inc. (KVUE)
RBC Capital Sticks to Its Hold Rating for Kenvue, Inc. (KVUE)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KVUE | $17.43 | -0.6% | 11.32M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |